|
|
此文章由 melon123 原创或转贴，不代表本站立场和观点，版权归 oursteps.com.au 和作者 melon123 所有！转贴必须注明作者、出处和本声明，并保持内容完整
有兴趣的可以去读一下这篇文章。是关于美国2019年12月至2020年1月献血者人中COVID抗体阳性比率的。
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus
2 (SARS-CoV-2)–Reactive Antibodies: December 2019–January 2020
Sridhar V. Basavaraju,1 Monica E. Patton,1 Kacie Grimm,2 Mohammed Ata Ur Rasheed,2 Sandra Lester,2 Lisa Mills,3 Megan Stumpf,3 Brandi Freeman,1 Azaibi Tamin,1 Jennifer Harcourt,1 Jarad Schiffer,1 Vera Semenova,1 Han Li,1 Bailey Alston,4 Muyiwa Ategbole,5 Shanna Bolcen,1 Darbi Boulay,1 Peter Browning,1 Li Cronin,1 Ebenezer David,6 Rita Desai,1Monica Epperson,1 Yamini Gorantla,5 Tao Jia,1 Panagiotis Maniatis,1 Kimberly Moss,4 Kristina Ortiz,4 So Hee Park,4 Palak Patel,6 Yunlong Qin,4 Evelene Steward-Clark,1 Heather Tatum,5 Andrew Vogan,4 Briana Zellner,7 Jan Drobeniuc,1 Matthew R. P. Sapiano,1 Fiona Havers,1 Carrie Reed,1 Susan Gerber,1 Natalie J. Thornburg,1 and Susan L. Stramer2
1Centers for Disease Control and Prevention, Atlanta, Georgia, USA, 2American Red Cross, Scientific Affairs, Gaithersburg, Maryland, USA, 3Synergy America, Inc, Atlanta, Georgia, USA, 4Eagle Global Scientific, Atlanta, Georgia, USA, 5IHRC, Atlanta, Georgia, USA, 6CFD Research Corporation, Huntsville, Alabama, USA, and 7Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA
Background. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China, in December 2019, with subsequent worldwide spread. The first US cases were identified in January 2020.
Methods. To determine if SARS-CoV-2–reactive antibodies were present in sera prior to the first identified case in the United States on 19 January 2020, residual archived samples from 7389 routine blood donations collected by the American Red Cross from 13 December 2019 to 17 January 2020 from donors resident in 9 states (California, Connecticut, Iowa, Massachusetts, Michigan, Oregon, Rhode Island, Washington, and Wisconsin) were tested at the Centers for Disease Control and Prevention for anti–SARS- CoV-2 antibodies. Specimens reactive by pan-immunoglobulin (pan-Ig) enzyme-linked immunosorbent assay (ELISA) against the full spike protein were tested by IgG and IgM ELISAs, microneutralization test, Ortho total Ig S1 ELISA, and receptor-binding do- main/ACE2 blocking activity assay.
Results. Of the 7389 samples, 106 were reactive by pan-Ig. Of these 106 specimens, 90 were available for further testing. Eighty- four of 90 had neutralizing activity, 1 had S1 binding activity, and 1 had receptor-binding domain/ACE2 blocking activity >50%, suggesting the presence of anti–SARS-CoV-2–reactive antibodies. Donations with reactivity occurred in all 9 states.
Conclusions. These findings suggest that SARS-CoV-2 may have been introduced into the United States prior to 19 January 2020.
|
|
圣诞礼物DIY -- E&E -- Mila‘s Monster Face Meal (2011-12-22) 闲夏采薇 
发表于 2021-4-11 14:23
发表于 2021-4-11 14:27
